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To the Editor,
Cholelithiasis is uncommon in neonates and infants and is usually associated with
predisposing factors such as congenital abnormalities of the biliary tract, hemolytic
diseases, total parenteral nutrition (TPN) administration, congenital heart disease, and
prolonged fasting. Infants with complications of prematurity are more predisposed to
development of biliary calculi. Cholelithiasis may also develop due to use of some
medications. Recent studies demonstrated ceftriaxone as inducing reversible
precipitations in the gallbladder that mimic cholelithiasis (1). This complication is termed
‘biliary pseudolithiasis’ or ‘reversible cholelithiasis’. Reversible biliary sludge and/or
lithiasis appears to be a temporary, self-limiting phenomenon. To our knowledge, no
patient has been reported in the literature with biliary pseudolithiasis due to TPN. In this
paper, we describe a premature newborn that developed biliary pseudolithiasis after 30
days of TPN therapy, which completely resolved 11 days after the end of the treatment.
A premature female baby born at 30 weeks of gestational age was admitted to our
neonatology department with complaints of respiratory distress and cyanosis. She was
resuscitated and required mechanical ventilation. Ampicillin (100 mg/kg), amikacin (15
mg/kg) and TPN were initiated. She underwent mechanical ventilation treatment for
three days. On the third day of hospitalization, oral feeding was attempted but was not
tolerated. On the 12th day after birth she showed signs of a sudden septic condition.
Antibiotic regimen was changed to vancomycin (15 mg/kg/dose b.i.d.) and meropenem
(20 mg/kg/dose b.i.d.). Blood culture of the infant was coagulase-negative
staphylococcus. Anti-biotherapy was given for 10 days. Because of septic condition and
oral intolerance, TPN was continued for 30 days after birth. On the 30th day of life, due
to prominent abdominal distention, we performed abdominal ultrasonography (USG),
which showed biliary sludge with mobile echogenic foci with poor acoustic shadowing in
the gallbladder lumen that were demonstrated as gallstones (Figure 1). Hematological
(hemoglobin, white blood cell count, platelet count) and biochemical analyses of the
blood (total and direct bilirubin, liver function tests, blood urea nitrogen, creatinine and
lipids) were performed in the patient. Biochemical parameters were within normal
ranges. TPN treatment was discontinued after the diagnosis of cholelithiasis. She was
given ursodeoxycholic acid (15 mg/kg/dose b.i.d.) orally. After beginning
ursodeoxycholic acid treatment, she tolerated oral nutrition and her clinical condition
began to improve. After ursodeoxycholic acid treatment for 11 days, USG revealed
resolution of the calculi and biliary sludge (Figure 2).
Cholelithiasis in neonates and infants has been reported only rarely. It is usually
associated with known predisposing factors such as hemolysis, congenital anomalies of
the biliary tree, TPN, congenital heart disease, and prolonged fasting. Reversible biliary
sludge and/or lithiasis, named as pseudolithiasis, have been reported in patients treated
with ceftriaxone (2,3). Araz et al. (2) observed ceftriaxone-associated pseudolithiasis in
eight patients treated for meningitis. After ceftriaxone treatment was discontinued,
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Figure 1. Abdominal USG showed biliary sludge with mobile echogenic
foci with poor acoustic shadowing in the gallbladder lumen
that were demonstrated as gallstones.

Figure 2. Follow-up USG revealed resolution of the calculi and biliary
sludge.

gallbladder sonograms were found to be normal in all
patients at the follow-up sonographic examinations.
Herek et al. (1) also described a patient who developed
biliary pseudolithiasis after six days of ceftriaxone
therapy, which completely resolved 11 days after the end
of the treatment

as the result of Gram-negative bacilli, may have a
lithogenic effect on bile by decreasing the independent
bile salt flow. In the blood culture of our patient,
coagulase- negative staphylococcus was isolated. Since
gallbladder stone and sludge did not occur during septic
condition but 10 days after sepsis, it was not considered
as an etiologic factor for biliary pseudolithiasis.

TPN-associated biliary sludge and/or calculi usually do
not resolve spontaneously and may require surgery. Our
patient did not have hemolytic disease, dehydration,
urinary tract infection, or cholestatic liver disease and did
not take third-generation cephalosporin. She had only
received TPN. The only risk factor for pseudolithiasis
formation in our patient was prolonged TPN treatment
and prematurity. Holcomb et al. (4) attributed most of
the gallstones diagnosed from birth to 2 years of age to
the use of TPN in premature infants. Infection, especially

In this case, we want to emphasize prolonged TPN
treatment as an etiological factor for biliary
pseudolithiasis in premature infants. It appears to be a
temporary, self-limiting phenomenon, and an aggressive
approach is not warranted in premature infants. Since it
may disappear without surgery, in the absence of other
clinical or imaging evidence of biliary tract disease,
conservative management and serial sonograms are
advised.
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